Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

The spiroindolone KAE609 does not induce dormant ring stages in Plasmodium falciparum parasites

Diagana, Thierry Tidiane, Chavchich, Marina, Van Breda, Karin, Rowcliffe, Kerryn and Edstein, Michael (2016) The spiroindolone KAE609 does not induce dormant ring stages in Plasmodium falciparum parasites. Antimicrobial Agents and Chemotherapy, 60 (9). pp. 5167-5174. ISSN 1098-6596


In vitro drug treatment with artemisinin derivatives, such as dihydroartemisinin (DHA), results in a temporary growth arrest (i.e., dormancy) at an early ring stage in Plasmodium falciparum. This response has been proposed to play a role in the recrudescence of P. falciparum infections following monotherapy with artesunate and may contribute to the development of artemisinin resistance in P. falciparum malaria. We demonstrate here that artemether does induce dormant rings, a finding which further supports the class effect of artemisinin derivatives in inducing the temporary growth arrest of P. falciparum parasites. In contrast and similarly to lumefantrine, the novel and fast-acting spiroindolone compound KAE609 does not induce growth arrest at the early ring stage of P. falciparum and prevents the recrudescence of DHA-arrested rings at a low concentration (50 nM). Our findings, together with previous clinical data showing that KAE609 is active against artemisinin-resistant K13 mutant parasites, suggest that KAE609 could be an effective partner drug with a broad range of antimalarials, including artemisinin derivatives, in the treatment of multidrug-resistant P. falciparum malaria.

Item Type: Article
Date Deposited: 28 Nov 2017 00:45
Last Modified: 25 Jan 2019 00:45


Email Alerts

Register with OAK to receive email alerts for saved searches.